IBX 5.00% 3.8¢ imagion biosystems limited

Ann: First-in-human Study Progress Update, page-16

  1. 47 Posts.
    lightbulb Created with Sketch. 289

    Hello everyone

    IBX has just released an announcement updating the markets on the progress of the MagSense®HER2 breast cancer study.


    Highlights of this announcement include:

    • Interim data supports MagSense® imaging agent is safe and well-tolerated
    • Results make evident that the imaging agent is reaching the patient’s lymph nodes


    CEO Bob Proulxindicates “We are encouraged by these preliminary observations…”


    Read the full announcement here: https://imagionbiosystems.com/news/magsense_her2-breast-cancer-first-in-human-study-progress-update/

    Last edited by ImagionBio: 17/03/22
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.002(5.00%)
Mkt cap ! $1.329M
Open High Low Value Volume
4.0¢ 4.4¢ 3.8¢ $1.204K 30.03K

Buyers (Bids)

No. Vol. Price($)
2 16942 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 666 2
View Market Depth
Last trade - 15.59pm 16/08/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.